Abstract:Dermal fibrosis is characterized by the activation of the matrix-producing 'positive' myofibroblasts, and the relentless production and deposition of extracellular matrix. The hedgehog pathway has recently been demonstrated to work in a pro-fibrotic manner in systemic sclerosis (SSc). A negative regulator of the hedgehog pathway (Hh), the suppressor of fused (Sufu), was shown to be involved in the activation of fibrotic diseases. However, the exact role of Sufu in fibrosis has not been investigated so far. In our study, we aimed to define the role of sufu in the process of fibrosis using dermal fibroblasts of healthy donors that were cultured in vitro. Cyclopamine, a Smo antagonist, and Sufu lentivector were used to treat or transfect cells. The expression of fibrosis markers and ERK1/2, Smad2, and GSK3β at the protein level was determined by Western blot. Fibroblast migration was measured by in vitro wound healing assay. Bleomycin-induced dermal fibrosis mouse model was introduced to assess the effect of cyclopamine on dermal fibrosis in vivo. We found that cyclopamine significantly upregulated the expression of Sufu. Both cyclopamine and Sufu lentivector reduced migration and myofibroblast differentiation of human dermal fibroblasts at a statistically significant level. Furthermore, cyclopamine reversed dermal fibrosis induced by TGF-β1. Cyclopamine and the overexpression of Sufu inhibited the phosphorylation of GSK-3β and restrained the migration of fibroblasts. Dermal fibrosis was inhibited by intraperitoneal injection of cyclopamine in a mouse model of scleroderma. Our findings suggest that cyclopamine and Sufu-overexpression may effectively inhibit the endogenous as well as the TGF-β1-induced activation of fibroblasts through subsequent activation of GSK-3β. Sufu agonists may be a promising approach in the development of antifibrotic medications for dermal fibrosis and systemic sclerosis.

Sef-S, an Alternative Splice Isoform of Sef Gene, Inhibits NIH3T3 Cell Proliferation Via a Mitogen-Activated Protein Kinases P42 and P44 (Erk1/2)-Independent Mechanism.

Hsef Inhibits Pc-12 Cell Differentiation by Interfering with Ras-Mitogen-Activated Protein Kinase Mapk Signaling

Hsef Potentiates EGF-mediated MAPK Signaling Through Affecting EGFR Trafficking and Degradation

Hsef Co-Localizes and Interacts with Ras in the Inhibition of Ras/MAPK Signaling Pathway

Tyrosine 330 in Hsef is Critical for the Localization and the Inhibitory Effect on FGF Signaling

C-Cbl Mediated Ubiquitination and Degradation of Hsef

Differential regulation of Gli proteins by Sufu in the lung affects PDGF signaling and myofibroblast development.

[Construction and Characterization of Hsef Recombinant Adenoviral Vectors].

Activation of TAK1 by Sef-S Induces Apoptosis in 293T Cells

Sec3 Knockdown Inhibits TGF-β Induced Epithelial-Mesenchymal Transition Through the Down-Regulation of Akt Phosphorylation in A549 Cells.

Expression of Hsef in Various Human Tissues and Cell Lines

Smad4 Sequestered in SFPQ Condensates Prevents TGF-β Tumor-Suppressive Signaling.

Suppressor of Fused Inhibits Skin Wound Healing

Reexpression of the Major PKC Substrate, SSeCKS, Correlates with the Tumor‐Suppressive Effects of SCH51344 on Rat‐6/src and Rat‐6/ras Fibroblasts but Not on Rat‐6/raf Fibroblasts

Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.

SRSF6-regulated Alternative Splicing That Promotes Tumour Progression Offers a Therapy Target for Colorectal Cancer

Identification of M-Sec as a unique cellular regulator of CSF-1 receptor activation

Inhibition of the Hedgehog Pathway Leads to Antifibrotic Effects in Dermal Fibrosis

Single‐Cell RNA Sequencing Reveals Heterogeneity of Myf5‐Derived Cells and Altered Myogenic Fate in the Absence of SRSF2

Zebrafish Suppressor of Cytokine Signaling 4b (Socs4b) Is Dispensable for Development but May Regulate Epidermal Growth Factor Receptor Signaling

LIF Promotes Sec15b‐Mediated STAT3 Exosome Secretion to Maintain Stem Cell Pluripotency in Mouse Embryonic Development